Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Headache from overuse of medication].

O Meienberg1

  • 1Praxis für Neurologie, Binningen. otmar.meienberg@hin.ch

Therapeutische Umschau. Revue Therapeutique
|April 15, 2006
PubMed
Summary

Medication overuse headache (MOH) affects 1% of people and is rising, especially in adolescents. Treating MOH requires drug withdrawal, as other headache treatments are ineffective during overuse.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporary Medial Upper Eyelid Lagophthalmos after External Dacryocystorhinostomy.

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

[Preventive treatment of migraine and chronic tension headache with moclobemide].

Praxis·1997
Same author

Cold-induced acral vasospasm in migraine as assessed by nailfold video-microscopy: prevalence and response to migraine prophylaxis.

Angiology·1997
Same author

Moclobemide in the prophylactic treatment of migraine. A retrospective analysis of 44 cases.

European neurology·1996
Same author

[Vertigo and migraine].

Schweizerische medizinische Wochenschrift·1993
Same author

Deterioration or onset of migraine under oestrogen replacement therapy in the menopause.

Journal of neurology·1993

Area of Science:

  • Neurology
  • Pharmacology

Context:

  • Medication overuse headache (MOH) affects approximately 1% of the general population.
  • Prevalence is expected to increase due to rising medication overuse among adolescents.
  • The International Classification of Headache Disorders provides diagnostic criteria for MOH subtypes.

Purpose:

  • To outline diagnostic criteria for recognizing and differentiating MOH caused by specific drug classes.
  • To emphasize the importance of drug withdrawal as the primary treatment for MOH.
  • To highlight the ineffectiveness of long-term headache treatments during active medication overuse.

Summary:

  • MOH predominantly affects individuals with a history of migraine or chronic tension-type headache, suggesting a potential genetic predisposition.
  • Treatment involves discontinuing the overused medication; long-term therapies are ineffective during overuse.
  • Relapse rates vary by substance, underscoring the critical need for prophylaxis in at-risk populations.

Impact:

  • Informing clinical practice for accurate MOH diagnosis and management.
  • Guiding preventative strategies for individuals with chronic headache disorders.
  • Reducing the long-term burden of medication overuse headache through targeted interventions.

Related Experiment Videos